• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Startup Aortica raises $7m in Series A round, names Douthitt CEO

Startup Aortica raises $7m in Series A round, names Douthitt CEO

November 21, 2014 By Brad Perriello

Aortica raises $7m in Series A round, names new CEO

Aortica said it raised $7 million in a Series A round for development of its treatment for abdominal aortic aneurysms and named a medtech veteran as its new CEO.

Aortica said medtech veteran Tom Douthitt will helm the corner office, with co-founder Dr. Ben Starnes serving as chief medical officer.

Aortica plans to use the proceeds from the Series A round to complete a pivotal study for a treatment aimed at AAA patients who are unable to undergo endovascular surgery because of certain anatomical abnormalities.

Douthitt told MassDevice.com today via email that the Series A round "was comprised entirely of angel investors and represents the 1st investment in the company." Aortica was formed Sept. 8 and the funding closed on Nov. 7, he told us.

According to its website, Aortica’s endovascular aneurysm repair device is designed to be customized to each patient’s anatomy.

“Approximately 30% to 40% of patients diagnosed annually in the U.S. with moderate to severe AAA disease are ineligible for less invasive endovascular therapy due to anatomical limitations,” Starnes said in prepared remarks. “Aortica has developed an approach designed to allow standard endografts to be customized to fit each patient’s unique anatomy. Consequently, patients who previously were faced with a highly invasive surgical course now will have the option of far less invasive endovascular aneurysm repair."

Douthitt said he began his career in medtech at Eli Lilly‘s (NYSE:LLY) medical device division in 1987 and stayed with Guidant when it spun out from Lilly in 1995. After 5 years at Guidant, he wrote, he left to become vice president of sales & marketing at a medical device startup, but by 2002 he was recruited to become general manager of Abbott Vascular‘s (NYSE:ABT) coronary business.

Stints at 3 more medtech startups followed from 2004 to 2014, Douthitt told us, noting that Aortica is the 5th early-stage venture he’s been involved with but his 1st as CEO.

Val Kennedy contributed to this report.

Filed Under: Funding Roundup, News Well Tagged With: Aortica, Endovascular

More recent news

  • Mount Sinai adopts Flosonics wearable ultrasound device
  • GE HealthCare launches next-gen intraoperative ultrasound
  • Philips launches new point-of-care ultrasound system
  • Medtronic to invest $50M in India Diabetes center
  • Corvia Medical raises $55M as it seeks FDA nod for atrial shunt

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy